The need to make insulin affordable for all Americans : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighteenth Congress, first session on examining the need to make insulin affordable for all Americans, May 10, 2023.

Author/creator United States
Format Electronic
PublicationWashington : U.S. Government Publishing Office, 2024.
Description1 online resource (iii, 111 pages).
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo224402
Subjects

SeriesS. hrg. ; 118-198
United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 118-198. ^A500722
General noteAccess ID (govinfo): CHRG-118shrg54476.
General noteIn scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Performer Hearing witnesses: Ricks, David, Chair and Chief Executive Officer, Eli Lilly and Company, Indianapolis, IN; Hudson, Paul, Chief Executive Officer, Sanofi, Paris, France; Jorgensen, Lars Fruergaard, President and Chief Executive Officer, Novo Nordisk, Bagsvaerd, Denmark; Joyner, David, Executive Vice President and President of Pharmacy Services, CVS Health, Woonsocket, RI; Kautzner, Adam, President, Express Scripts, St. Louis, MO; Cianfrocco, Heather, Chief Executive Officer, OptumRx, Eden Prairie, MN.
Date/time/place of a event noteDate of hearing: 2023-05-10.
Source of descriptionDescription based on online resource; title from PDF title page (GovInfo, viewed April 22, 2024).
Issued in other formPrint version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Need to make insulin affordable for all Americans
Genre/formLegislative hearings.
Standard identifier# 54-476 (GPO jacket number)
GPO item number1043-C (online)
Govt. docs number Y 4.L 11/4:S.HRG.118-198